In our previous study, which included extra 120 HCC patients beyond MC who underwent RR were included, significant differences in the RFS rates were observed between the patients of the CK19+/GPC3+ and CK19−/GPC3+ or CK19−/GPC3− groups [12]. Here, KRT19 is linked to hepatocellular carcinoma.